Docus
Docus is an AI-native B2B SaaS platform that provides diagnostic laboratories with interpretation, compliance, requisition, and patient-engagement modules, deployed via API/HL7 or no-code interfaces. It serves direct-to-consumer, reference, and in-house labs globally with 800+ customers.
- Company typePrivate
- Founded2021
- HeadquartersWilmington, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Docus does
Docus is a B2B SaaS company building an AI Layer for diagnostic laboratories, founded in 2021 and headquartered in Wilmington, United States. The platform unifies five AI-driven modules — Interpretation Reports (clinical and patient-friendly test analysis with differential diagnosis, follow-up suggestions, and clinical plans), Follow-Up Recommendations (retention-driving next-test suggestions and notifications), an AI Compliance Agent (medical necessity and Test Order–ICD validation), Digital Requisitions (AI-validated ordering with auto-generated medical necessity text and digital signatures), and Context-Aware AI Assistants for clinicians and patients. The platform serves three lab archetypes: direct-to-consumer labs, reference labs, and in-house hospital/clinic labs, with deployment flexibility via API/HL7 integration into LIS, CRM, or EHR systems, or through no-code Docus Interfaces for immediate onboarding.
The company monetizes through an enterprise SaaS subscription model with annual billing, using a quote-based sales motion complemented by demo-driven field sales and self-serve PLG for mid-market labs. Distribution is global, with named customers including Blood Cells Laboratories, Lifepoint, LigoLab, Unity Lab Solutions, Global Diagnostic Lab, Hexalud, Prom-Test Laboratories, Arabkir Medical Centre, AMC Astghik Medical Center, Laboratorio Ramos, Erebouni Medical Center, AllState, Genics, and Prolabor — a footprint spanning the US, Armenia, Latin America, and other regions. The company claims 800+ diagnostic labs on the platform and reports quantified customer outcomes including 230% test volume growth and a follow-up testing rate increase from 5% to 27% in its flagship Blood Cells Laboratories case study.
Docus has raised approximately $1.25M in disclosed seed funding across two rounds (June 2022: $500K from BigStory VC and Formula VC; February 2023: $750K from Triple S Ventures) and operates with 11–50 employees. Leadership comprises CEO and co-founder Robert Sargsyan and CTO and co-founder Gevorg Nazaryan. The company maintains enterprise-grade compliance with SOC 2 Type 2, HIPAA, and GDPR certifications and publishes thought-leadership research through its Docus Research Team, including the AI in Healthcare Statistics 2025 report.
Docus firmographics
Firmographics- Name
- Docus
- Website
- https://docus.ai/
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Docus is an AI-native B2B SaaS platform that provides diagnostic laboratories with interpretation, compliance, requisition, and patient-engagement modules, deployed via API/HL7 or no-code interfaces. It serves direct-to-consumer, reference, and in-house labs globally with 800+ customers.
- Ownership category
- akta.pro rank
Docus industry classification
Industry- Product category
- Healthcare AI Software for Diagnostic Laboratories
- NAICS
- Software Publishers (5132), Custom Computer Programming Services (541511), Medical Laboratories (621511)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming Services (7371), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
- akta.pro secondary industries
- Medical Billing & Coding Automation (HLACACAA), Patient Intake, Digital Registration & eForms (HLACAEAF), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
Keywords
Where Docus is headquartered
LocationHeadquarters
- HQ city
- Wilmington
- HQ country
- United States
- HQ region
- North America
Markets served
Docus business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- SaaS Platform Subscription: Docus operates as a B2B SaaS platform providing AI solutions to diagnostic labs. The platform is offered through direct sales and API integration, suggesting a subscription-based model with pricing tiers based on lab size, test volume, or feature access.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS for diagnostic labs |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Docus product offering
Product offeringCore offering
Docus sells a B2B SaaS "AI Layer" for diagnostic laboratories, providing AI-powered Interpretation Reports, Follow-Up Recommendations, an AI Compliance Agent (Test Order–ICD validation and repeat-frequency checks), AI-validated Digital Requisitions, and Context-Aware AI Assistants for doctors and patients. The platform is delivered either through API/HL7 integration with lab information systems or via no-code Docus Interfaces for immediate onboarding, targeting reference labs, direct-to-consumer labs, and in-house hospital/clinic laboratories.
Product overview
Docus is an AI-powered health platform providing an AI Layer for Modern Diagnostic Labs. The platform offers a unified solution with five core modules: Interpretation Reports (clinical and patient-friendly test result analysis), Follow-Up Recommendations (AI-powered retention and care continuity), AI Compliance Agent (automated medical necessity and order validation), Digital Requisitions (AI-validated ordering workflows), and Context-Aware AI Assistants (clinical and patient support). The platform supports three lab models: Direct-to-Consumer Labs, Reference Labs, and In-House Labs/Clinics. Docus also publishes industry research through its Docus Research Team, including the AI in Healthcare Statistics 2025 report. All modules can be deployed via API/HL7 integration or no-code Docus interfaces.
Differentiator
Problem solved
Functional benefit
Products and services
- Interpretation Reports AI-powered interpretation of diagnostic lab test results that produces clinical reports with differential diagnosis (DDx), follow-up suggestions, and clinical plans for doctors, plus patient-friendly explanations of results in simple language. Supports routine and specialty tests including pathology, PGx, and infectious disease, and uses historical patient test data for context-aware analysis.
- Follow-Up Recommendations AI-driven follow-up module that recommends next tests and follow-up steps based on lab results and identified risks, sends timely notifications to patients for care continuity, and allows doctors to set manual consultation reminders to improve retention and care continuity at the lab.
- AI Compliance Agent Automated compliance checking service that performs Test Order–ICD validation, verifies repeat testing frequency rules, conducts pre- and post-test reviews, and alerts labs and ordering doctors when issues are detected to prevent denials, reduce audit risk, and minimize compliance losses.
- Digital Requisitions AI-validated digital requisition system with autocomplete, select options, and guided inputs for faster order completion, AI-generated medical necessity text, digital signature workflows for consent, and automatic routing of completed requisitions to the lab's Docus interface or directly into its LIS.
- Context-Aware AI Assistants AI assistant offering providing context-aware clinical support for doctors based on patient data and history, and educational responses in simple language for patients with suggested doctor follow-up when appropriate. Uses patient history and lab results to deliver more relevant, personalized answers.
- AI Layer for Diagnostic Labs (Platform) Unified AI platform serving direct-to-consumer labs, reference labs, and in-house labs/clinics that integrates Interpretation Reports, Follow-Up Recommendations, AI Compliance Agent, Digital Requisitions, and Context-Aware AI Assistants, deployable via API/HL7 integration with LIS, CRM, or EHR systems or through no-code Docus Interfaces for immediate onboarding.
Quantifiable outcome
- 230% test volume growth for Blood Cells Laboratories after 12 months of using Docus
- +2 more outcomes
Companies that use Docus
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles2 records
Docus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability9 records
Feature5 records
Docus partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights6 records
Docus competitors and assessment
Company assessmentDirect peers
- LigoLab: LigoLab is a laboratory information system (LIS) provider for diagnostic labs. Docus lists LigoLab as a partner, but LigoLab also competes with Docus by embedding AI-driven interpretation, compliance, and requisition capabilities into its own platform — making it both a channel partner and direct competitor in lab workflow software.
- hc1: hc1 is a healthcare analytics and lab insights platform that turns lab data into actionable insights for diagnostic labs and health systems. It is directly comparable to Docus's interpretation, follow-up, and patient-engagement modules, both targeting lab operators with AI-driven decision support.
- AKASA: AKASA builds AI for healthcare revenue cycle operations, including medical necessity checks and denial prevention. It directly parallels Docus's AI Compliance Agent module and targets the same healthcare financial/operational buyer.
Emerging players
- PathAI: PathAI applies AI to pathology and diagnostic interpretation. While its primary focus is pathology rather than the full lab menu, it competes with Docus on the AI interpretation layer for specialty tests and shares the same enterprise lab buyer.
- Suki AI: Suki provides AI assistants for clinicians that summarize encounters, draft notes, and surface clinical context. Its doctor-facing AI assistant overlaps with Docus's Context-Aware AI Assistant for doctors, though Suki focuses on documentation rather than lab interpretation.
- Arterys: Arterys offers AI-powered clinical workflow and imaging analytics platforms deployed in hospitals. While it is more imaging-focused, it shares Docus's strategy of layering AI interpretation and decision support into clinical workflows via enterprise integrations.
Broad incumbents
- Tempus Labs: Tempus is a large, well-capitalized AI-driven precision medicine company with diagnostics, interpretation, and clinical decision support capabilities. It overlaps with Docus in AI-enabled test interpretation but operates at much greater scale and breadth.
- Sunquest Information Systems (Clinisys): Sunquest/Clinisys is an established LIS vendor serving diagnostic labs globally. It overlaps with Docus across lab workflow, order management, and result delivery, and is increasingly layering AI capabilities into its platform.
- Oracle Health (formerly Cerner): Oracle Health operates one of the dominant EHR/LIS platforms used by hospitals and reference labs. It competes with Docus through embedded clinical decision support, compliance checks, and result interpretation features, and brings massive distribution to the same buyers.
- Epic Systems: Epic is the largest US EHR vendor and is rapidly embedding AI capabilities into its platform, including result interpretation and decision support. As a system-of-record for many hospital labs, it represents the most formidable incumbent competitor to Docus's in-house lab use case.
Market position
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Docus social profiles
Digital presenceDocus compliance and trust
Trust signalCompliance3 records
Docus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Docus leadership team
Management profileNumber of profiles
Profiles2 records
Docus funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Docus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Docus
What does Docus do?
Docus sells a B2B SaaS "AI Layer" for diagnostic laboratories, providing AI-powered Interpretation Reports, Follow-Up Recommendations, an AI Compliance Agent (Test Order–ICD validation and repeat-frequency checks), AI-validated Digital Requisitions, and Context-Aware AI Assistants for doctors and patients. The platform is delivered either through API/HL7 integration with lab information systems or via no-code Docus Interfaces for immediate onboarding, targeting reference labs, direct-to-consumer labs, and in-house hospital/clinic laboratories.
When was Docus founded?
Docus was founded in 2021. It employs 11 to 50 people.
Where is Docus based?
Docus is headquartered in Wilmington, United States, in the North America region.
How does Docus make money?
One revenue line is on record: saaS Platform Subscription.
Who are Docus's main competitors?
Direct peers on record are LigoLab, hc1 and AKASA. Emerging players are PathAI, Suki AI and Arterys. Broad incumbents are Tempus Labs, Sunquest Information Systems (Clinisys), Oracle Health (formerly Cerner) and Epic Systems.
Does Docus have an API?
Yes. Docus offers API/HL7 integration for diagnostic labs. Labs can send lab data via API/HL7 and receive structured interpretation reports and other outputs directly in their LIS, CRM, or EHR.
What industry is Docus in?
Docus's product category is Healthcare AI Software for Diagnostic Laboratories. Its primary akta.pro industry code is HLAAALAO, Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays), with a secondary code of HLACACAA, Medical Billing & Coding Automation. Its NAICS code is 5132 and its SIC code is 7372.